FDA Approves CDx to Determine Gene Therapy Eligibility for Hemophilia B Patients
The FDA approved Labcorp’s companion diagnostic test designed to determine eligibility for Pfizer’s gene therapy for hemophilia B patients.
Read MorePosted by Andy Lundin | Apr 29, 2024 | Disease States |
The FDA approved Labcorp’s companion diagnostic test designed to determine eligibility for Pfizer’s gene therapy for hemophilia B patients.
Read MorePosted by Andy Lundin | Apr 29, 2024 | Molecular Diagnostics |
GenomOncology announced enhancements to its Pathology Workbench software, which features improved support for germline and somatic testing.
Read MorePosted by Andy Lundin | Apr 29, 2024 | Molecular Diagnostics |
Cardio Diagnostics’s multiomic DNA test showed an ability to save up to $113.6 million annually for a health plan with one million members.
Read MorePosted by Andy Lundin | Apr 24, 2024 | Molecular Diagnostics |
The partnership aims to provide patients with greater accessibility and convenience in accessing whole genome sequencing tests.
Read MorePosted by Andy Lundin | Apr 23, 2024 | Heart Disease |
Researchers in the U.S. and the Netherlands have now used a large dataset to build more accurate cardiovascular risk models.
Read More